P75 Guidance for Integrated Prevention and Treatment Services for Persons Who Use Drugs Illicitly

Tuesday, March 13, 2012
Hyatt Exhibit Hall
Salaam Semaan, DrPH, National Center for HIV/AIDS, viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Kevin O'Connor, MA, Program and Training Branch, Centers for Disease Control and Prevention, Atlanta, GA, Franklin Fletcher, BBA, Division of STD Prevention, CDC, Atlanta, GA and CDC's NCHHSTP Drug Use Prevention Workgroup, MD, PhD, DHAP, DSTDP, DVH, DTB, CDC, Atlanta, GA

Background:Recommendations for preventing and treating HIV, viral hepatitis, STDs, TB, substance abuse disorders, and mental disorders among persons who use drugs illicitly appear in different publications. Synthesizing this literature in one document, and building on recent comprehensive, combination, and integrated service-delivery innovations can enhance access to information, efficiency and cost of service delivery, reduce visits to different facilities, and improve health outcomes.

Objectives:To support and encourage efforts of stakeholders (e.g., public health agencies, service providers) in delivery of integrated services for persons who use drugs illicitly.

Methods:Practice recommendations as well as scientific and programmatic literature were synthesized in one document to support the needs of stakeholders who serve as leaders, managers, providers, and recipients of prevention and treatment services.

Results:The guidance promotes integrated delivery of comprehensive science-based, public health strategies and interventions: prevention and treatment of substance abuse disorders and mental disorders; outreach; risk assessment for illicit use of drugs; risk assessment for infectious diseases; screening, diagnosis and counseling for infectious disease; vaccination for infectious diseases; prevention of mother-to-child transmission of infectious diseases; reduction of risk behaviors (risk reduction programs and messages, treatment for substance abuse and mental disorders, condom availability); partner services and contact follow up; referrals and linkage to care;  treatment for infectious diseases; and integrated prevention services. Integrated services can address infections, disorders, and co-exiting conditions that share risk factors, behaviors, and social determinants.

Conclusions:The guidance encourages implementation of integrated services at venues that serve persons who use drugs illicitly and suggests steps (e.g., coordinating body, analysis of  local data, staff training, evaluation) to foster service integration.

Implications for Programs, Policy, and Research: The guidance outlines practical steps for planning, delivering, monitoring, and evaluating integrated services.